• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌性 Ras/ERK 信号激活 CDCP1 促进肿瘤侵袭和转移。

Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.

机构信息

Division of Metastasis and Invasion Signaling, National Cancer Center Research Institute, Tokyo, Japan. Department of Applied Chemistry, National Defense Academy, Yokosuka, Kanagawa, Japan.

Division of Metastasis and Invasion Signaling, National Cancer Center Research Institute, Tokyo, Japan.

出版信息

Mol Cancer Res. 2014 Oct;12(10):1449-59. doi: 10.1158/1541-7786.MCR-13-0587. Epub 2014 Jun 17.

DOI:10.1158/1541-7786.MCR-13-0587
PMID:24939643
Abstract

UNLABELLED

Involvement of Ras in cancer initiation is known, but recent evidence indicates a role in cancer progression, including metastasis and invasion; however, the mechanism is still unknown. In this study, it was determined that human lung cancer cells with Ras mutations, among other popular mutations, showed significantly higher expression of CUB domain-containing protein 1 (CDCP1) than those without. Furthermore, activated Ras clearly induced CDCP1, whereas CDCP1 knockdown or inhibition of CDCP1 phosphorylation by Src-directed therapy abrogated anoikis resistance, migration, and invasion induced by activated-Ras. Activation of MMP2 and secretion of MMP9, in a model of Ras-induced invasion, was found to be regulated through induction of phosphorylated CDCP1. Thus, CDCP1 is required for the functional link between Ras and Src signaling during the multistage development of human malignant tumors, highlighting CDCP1 as a potent target for treatment in the broad spectrum of human cancers associated with these oncogenes.

IMPLICATIONS

CDCP1 protein induced by oncogenic Ras/Erk signaling is essential for Ras-mediated metastatic potential of cancer cells.

摘要

未注明

已知 Ras 参与癌症的起始,但最近的证据表明它在癌症的进展中起作用,包括转移和侵袭;然而,其机制尚不清楚。在这项研究中,确定具有 Ras 突变的人类肺癌细胞(除了其他常见的突变外)比没有突变的细胞表现出更高水平的 CUB 结构域蛋白 1(CDCP1)表达。此外,激活的 Ras 明显诱导了 CDCP1,而 CDCP1 的敲低或 Src 定向治疗抑制 CDCP1 磷酸化则消除了由激活的 Ras 诱导的抗凋亡、迁移和侵袭。在 Ras 诱导的侵袭模型中发现,MMP2 的激活和 MMP9 的分泌是通过诱导磷酸化的 CDCP1 来调节的。因此,在人类恶性肿瘤的多阶段发展过程中,CDCP1 是 Ras 和 Src 信号之间功能性联系所必需的,这突出了 CDCP1 作为与这些致癌基因相关的广泛人类癌症治疗的有效靶点。

意义

由致癌性 Ras/Erk 信号诱导的 CDCP1 蛋白对于 Ras 介导的癌细胞转移潜能是必需的。

相似文献

1
Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.致癌性 Ras/ERK 信号激活 CDCP1 促进肿瘤侵袭和转移。
Mol Cancer Res. 2014 Oct;12(10):1449-59. doi: 10.1158/1541-7786.MCR-13-0587. Epub 2014 Jun 17.
2
CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.含CUB结构域蛋白1是肺腺癌中一种新的失巢凋亡抗性调节因子。
Mol Cell Biol. 2007 Nov;27(21):7649-60. doi: 10.1128/MCB.01246-07. Epub 2007 Sep 4.
3
CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.CUB 结构域蛋白 1 是人胰腺癌细胞的预后因子,促进细胞迁移和细胞外基质降解。
Cancer Res. 2010 Jun 15;70(12):5136-46. doi: 10.1158/0008-5472.CAN-10-0220. Epub 2010 May 25.
4
Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.CUB 结构域蛋白 1 信号抑制自噬对肺癌细胞锚定非依赖性存活至关重要。
Cancer Sci. 2013 Jul;104(7):865-70. doi: 10.1111/cas.12154. Epub 2013 Apr 19.
5
Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.CUB 结构域蛋白 1 信号通路在癌症侵袭和转移中的作用。
Cancer Sci. 2011 Nov;102(11):1943-8. doi: 10.1111/j.1349-7006.2011.02052.x. Epub 2011 Sep 6.
6
CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.CUB 结构域包含蛋白 1(CDCP1)激活 Src 以促进黑色素瘤转移。
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1379-84. doi: 10.1073/pnas.1017228108. Epub 2011 Jan 10.
7
The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.Src 相关蛋白含 CUB 结构域蛋白 1 调节黏附与运动。
Oncogene. 2012 Feb 2;31(5):653-63. doi: 10.1038/onc.2011.262. Epub 2011 Jul 4.
8
Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.酪氨酸激酶抑制剂拉帕替尼对含 CUB 结构域蛋白 1(CDCP1)介导的乳腺癌细胞存活和迁移的影响。
Biochem Biophys Res Commun. 2011 Oct 14;414(1):226-32. doi: 10.1016/j.bbrc.2011.09.062. Epub 2011 Sep 17.
9
CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.CDCP1 调节 MT1-MMP 的功能和侵袭性伪足介导的癌细胞侵袭。
Mol Cancer Res. 2013 Jun;11(6):628-37. doi: 10.1158/1541-7786.MCR-12-0544. Epub 2013 Feb 25.
10
CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.含CUB结构域蛋白1在实体癌中的过表达通过激活Src家族激酶促进癌细胞生长。
Oncogene. 2015 Oct 29;34(44):5593-8. doi: 10.1038/onc.2015.19. Epub 2015 Mar 2.

引用本文的文献

1
CDCP1-targeting ADC outperforms standard therapies in Ras-mutant pancreatic cancer.靶向CDCP1的抗体偶联药物在Ras突变型胰腺癌中优于标准疗法。
Mol Ther Oncol. 2025 Jul 21;33(3):201024. doi: 10.1016/j.omton.2025.201024. eCollection 2025 Sep 18.
2
Differential Role of CD318 in Tumor Immunity Affecting Prognosis in Colorectal Cancer Compared to Other Adenocarcinomas.与其他腺癌相比,CD318在影响结直肠癌预后的肿瘤免疫中的差异作用。
J Clin Med. 2025 Jul 19;14(14):5139. doi: 10.3390/jcm14145139.
3
Ligands of CD6: roles in the pathogenesis and treatment of cancer.
CD6的配体:在癌症发病机制和治疗中的作用
Front Immunol. 2025 Jan 7;15:1528478. doi: 10.3389/fimmu.2024.1528478. eCollection 2024.
4
Targeting CDCP1 boost CD8+ T cells-mediated cytotoxicity in cervical cancer via the JAK/STAT signaling pathway.通过 JAK/STAT 信号通路靶向 CDCP1 增强宫颈癌中 CD8+T 细胞介导的细胞毒性。
J Immunother Cancer. 2024 Oct 24;12(10):e009416. doi: 10.1136/jitc-2024-009416.
5
Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese.鉴定并多中心验证可溶性 CDCP1 作为肥胖中国人群 NASH 风险分层的稳健血清学生物标志物。
Cell Rep Med. 2023 Nov 21;4(11):101257. doi: 10.1016/j.xcrm.2023.101257. Epub 2023 Nov 1.
6
Defining the Functional Influence of Endothelial Cell-Expressed Oncogenic Activating Mutations on Vascular Morphogenesis and Capillary Assembly.定义内皮细胞表达的致癌激活突变对血管形态发生和毛细血管组装的功能影响。
Am J Pathol. 2024 Apr;194(4):574-598. doi: 10.1016/j.ajpath.2023.08.017. Epub 2023 Oct 12.
7
CRISPR-mediated reversion of oncogenic KRAS mutation results in increased proliferation and reveals independent roles of Ras and mTORC2 in the migration of A549 lung cancer cells.CRISPR 介导的致癌 KRAS 突变的逆转导致增殖增加,并揭示 Ras 和 mTORC2 在 A549 肺癌细胞迁移中的独立作用。
Mol Biol Cell. 2023 Dec 1;34(13):ar128. doi: 10.1091/mbc.E23-05-0152. Epub 2023 Sep 20.
8
The blood proteome of imminent lung cancer diagnosis.肺癌早期诊断的血液蛋白质组学。
Nat Commun. 2023 Jun 1;14(1):3042. doi: 10.1038/s41467-023-37979-8.
9
Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis.评估肺癌诊断前的血液蛋白测量值以预测生存。
EBioMedicine. 2023 Jun;92:104623. doi: 10.1016/j.ebiom.2023.104623. Epub 2023 May 24.
10
Anoikis resistance of small airway epithelium is involved in the progression of chronic obstructive pulmonary disease.小气道上皮的失巢凋亡抵抗参与慢性阻塞性肺疾病的进展。
Front Immunol. 2023 Apr 5;14:1155478. doi: 10.3389/fimmu.2023.1155478. eCollection 2023.